世界の動物用医薬品有効成分製造市場2021-2028:サービスタイプ別(社内、契約アウトソーシング)、合成タイプ別、製品別、地域別

◆英語タイトル:Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, Share & Trends Analysis Report By Service Type (In-house, Contract Outsourcing), By Synthesis Type, By Product, By Region, And Segment Forecasts, 2021 - 2028
◆商品コード:GV21MC129
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年1月29日
◆ページ数:102
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥678,300見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥792,300見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,020,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界の動物用医薬品有効成分製造市場規模が年平均6.9%成長し、2028年までに104億ドルに達すると予測しています。本調査レポートでは、動物用医薬品有効成分製造の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、サービスタイプ別(社内、契約アウトソーシング)分析、合成タイプ別(化学系API、生物学的API、HPAP)分析、製品別(駆虫剤、抗感染薬、NSAID、ワクチン、生物製剤)分析、地域別分析、競争分析、競争状況などを掲載しています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・動物用医薬品有効成分製造の世界市場規模:サービスタイプ別(社内、契約アウトソーシング)
・動物用医薬品有効成分製造の世界市場規模:合成タイプ別(化学系API、生物学的API、HPAP)
・動物用医薬品有効成分製造の世界市場規模:製品別(駆虫剤、抗感染薬、NSAID、ワクチン、生物製剤)
・動物用医薬品有効成分製造の世界市場規模:地域別
・競争分析
・競争状況
【レポートの概要】

Veterinary API Manufacturing Market Growth & Trends

The global veterinary active pharmaceutical ingredients manufacturing market size is expected to reach USD 10.4 billion by 2028, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.9% over the forecast period. The increasing prevalence of chronic diseases in animals and growing concerns among pet owners are the key contributors to the market growth.

Moreover, the growing prevalence of zoonotic diseases is driving the demand for drugs, which, in turn, boosts the demand for active pharmaceutical ingredients (APIs) for the production of these drugs. According to the Centers for Disease Control and Prevention (CDC), in July 2017, it was estimated that 6 out of 10 known infectious diseases in people can be transmitted from animals and 3 out of every 4 novel or emerging infectious diseases in people are caused due to animals.

Government organizations are involved in issuing various guidelines to promote veterinary services globally, which is expected to contribute to market growth in the coming years. For instance, in May 2018, the OIE International Standards, a part of the WTO framework, issued standards to improve animal health, which will affect human health as well. One of the key challenges was found to be the lack of technical expertise in this field.

The rising number of veterinarians is also anticipated to boost the market growth. According to the American Veterinary Medical Association, in 2018, there were 113,394 veterinarians in the U.S. as compared to 110,531 veterinarians in 2017. Out of these, 48,898 were involved in private clinical practice exclusively for companion animals. Also, according to the Canadian Veterinary Medical Association (CVMA), the approximate number of veterinarians in Canada is 12,921.

Veterinary API Manufacturing Market Report Highlights

• The contract outsourcing service type accounted for the largest revenue share of over 58% in 2020 owing to associated benefits with its usage

• The growing number of outsourcing activities by pharmaceutical companies is expected to boost the segment growth

• Chemical-based API synthesis type dominated the market in 2020. This can be attributed to its high usage by many major manufacturing companies

• The vaccines product segment held the largest market share of over 23% in 2020 due to increased demand for vaccines as a result of a high prevalence of chronic diseases in animals

• Due to the presence of well-established companies and technologically advanced infrastructure, North America dominated the market in 2020

• However, Asia Pacific is anticipated to register the fastest CAGR over the forecast period owing to the high potential and rapidly growing markets of India, Japan, and China

• Industry players are involved in strategies including mergers & acquisitions, collaborative agreements, and geographic expansions to gain a competitive edge

• For instance, in March 2020, SeQuent Scientific Ltd. received WHO-GENEVA approval for API Praziquantel, which is an anti-helminthic, under pre-qualification program in its Vizag, India facility

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List Of Secondary Sources
1.8 Objectives
1.8.1 Objective 1
1.8.2 Objective 2
1.8.3 Objective 3
1.8.4 Objective 4
Chapter 2 Executive Summary
2.1 Veterinary API manufacturing Market Summary
2.2 Segment Outlook
Chapter 3 Veterinary API manufacturing Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Pricing Analysis
3.4 Veterinary Api Manufacturing Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Increasing Prevalence Of Zoonotic Diseases
3.4.1.2 Increasing Animal Population And Pet Ownership
3.4.1.3 Growing Pet Expenditure
3.4.1.4 Rising Number Of Veterinarians And Veterinary Visits
3.4.1.5 Growing Demand For Pet Insurance
3.4.1.6 Strategic initiatives undertaken by market players
3.4.1.7 Growing Government Initiatives
3.4.2 Market Restraint Analysis
3.4.2.1 Stringent Government Regulations
3.4.2.2 Lack Of Awareness And High Cost Of Animal Care
3.4.3 Challenges
3.4.3.1 Illegal Veterinary Medicines
3.4.3.2 Veterinary Api Manufacturing Market Analysis Tools: Porters
3.4.4 Bargaining Power Of Suppliers: Low
3.4.5 Bargaining Power Of Buyers: Moderate
3.4.6 Threat Of Substitutes: Moderate
3.4.7 Threat Of New Entrants: Moderate
3.4.8 Competitive Rivalry: High
3.5 PEST Analysis
3.5.1 Political & Legal Landscape
3.5.2 Economic Landscape
3.5.3 Social Landscape
3.5.4 Technology Landscape
3.6 Forecast Analysis
3.6.1 Technologies & Trends In Api Manufacturing
3.6.2 Impact Of Covid-19 On The Veterinary Api Manufacturing Market
Chapter 4 Veterinary API manufacturing Market: Segment Analysis, By Service Type, 2016 – 2028 (USD Million)
4.1 Definition and Scope
4.2 Service Type Market Share Analysis, 2020 & 2028
4.3 Veterinary API manufacturing Market, by Service Type, 2016 to 2028
4.4 In-House
4.4.1 In-house market, 2016 – 2028 (USD Million)
4.5 Contract Outsourcing
4.5.1 Contract outsourcing market, 2016 – 2028 (USD Million)
4.5.2 Contract development
4.5.2.1 Contract development market, 2016 – 2028 (USD Million)
4.5.2.2 Preclinical Development
4.5.2.2.1 Preclinical development market, 2016 – 2028 (USD Million)
4.5.2.3 Others
4.5.2.3.1 Others market, 2016 – 2028 (USD Million)
4.5.3 Contract manufacturing
4.5.3.1 Contract manufacturing market, 2016 – 2028 (USD Million)
4.5.3.2 API/Bulk Drugs
4.5.3.2.1 API/bulk drugs market, 2016 – 2028 (USD Million)
4.5.3.3 Finished Dose Formulations
4.5.3.3.1 Finished dose formulations market, 2016 – 2028 (USD Million)
Chapter 5 Veterinary API manufacturing Market: Segment Analysis, By Synthesis Type, 2016 – 2028 (USD Million)
5.1 Definition and Scope
5.2 Synthesis Type Market Share Analysis, 2020 & 2028
5.3 Global Veterinary API manufacturing Market, by Synthesis Type, 2016 to 2028
5.4 Chemical-based API
5.4.1 Chemical-based api market, 2016 – 2028 (USD Million)
5.5 Biological API
5.5.1 Biological API market, 2016 – 2028 (USD Million)
5.6 HPAPI
5.6.1 HPAPI market, 2016 – 2028 (USD Million)
Chapter 6 Veterinary API manufacturing Market: Segment Analysis, By Product, 2016 – 2028 (USD Million)
6.1 Definition and Scope
6.2 Product Market Share Analysis, 2020 & 2028
6.3 Global Veterinary API manufacturing Market, by Product, 2016 to 2028
6.4 Antiparasitic
6.4.1 antiparasitic market, 2016 – 2028 (USD Million)
6.5 Anti-infectives
6.5.1 Anti-infectives market, 2016 – 2028 (USD Million)
6.6 NSAIDs
6.6.1 NSAIDs market, 2016 – 2028 (USD Million)
6.7 Vaccines
6.7.1 vaccines market, 2016 – 2028 (USD Million)
6.8 Biologics
6.8.1 Biologics market, 2016 – 2028 (USD Million)
6.9 Others
6.9.1 others market, 2016 – 2028 (USD Million)
Chapter 7 Veterinary API manufacturing Market: Regional Market Analysis, By Service Type, Synthesis Type, and By Product 2016 – 2028 (USD Million)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2020 & 2028
7.3 Regional Market Snapshot
7.4 Market Size, & Forecasts, and Trend Analysis, 2016 to 2028
7.5 North America
7.5.1 North America Market estimates and forecast by country, 2016 – 2028 (USD Million)
7.5.2 The U.S.
7.5.2.1 The U.S. Veterinary API manufacturing Market, 2016 – 2028 (USD Million)
7.5.3 Canada
7.5.3.1 Canada Veterinary API manufacturing Market, 2016 – 2028 (USD Million)
7.6 Europe
7.6.1 Europe Veterinary API manufacturing Market, by country, 2016 – 2028 (USD Million)
7.6.2 The U.K.
7.6.2.1 The U.K. Veterinary API manufacturing Market, 2016 – 2028 (USD Million)
7.6.3 Germany
7.6.3.1 Germany Veterinary API manufacturing Market, 2016 – 2028 (USD Million)
7.6.4 France
7.6.4.1 France Veterinary API manufacturing Market, 2016 – 2028 (USD Million)
7.6.5 Italy
7.6.5.1 italy Veterinary API manufacturing Market, 2016 – 2028 (USD Million)
7.6.6 Spain
7.6.6.1 spain Veterinary API manufacturing Market, 2016 – 2028 (USD Million)
7.7 Asia Pacific
7.7.1 Asia Pacific Veterinary API manufacturing Market, by country, 2016 – 2028 (USD Million)
7.7.2 Japan
7.7.2.1 Japan Veterinary API manufacturing Market, 2016 – 2028 (USD Million)
7.7.3 China
7.7.3.1 China Veterinary API manufacturing Market, 2016 – 2028 (USD Million)
7.7.4 India
7.7.4.1 India Veterinary API manufacturing Market, 2016 – 2028 (USD Million)
7.8 Latin America
7.8.1 Latin America Veterinary API manufacturing Market, by country, 2016 – 2028 (USD Million)
7.8.2 Brazil
7.8.2.1 Brazil Veterinary API manufacturing Market, 2016 – 2028 (USD Million)
7.8.3 Mexico
7.8.3.1 Mexico Veterinary API manufacturing Market, 2016 – 2028 (USD Million)
7.9 MEA
7.9.1 MEA Veterinary API manufacturing Market, by country 2016 – 2028 (USD Million)
7.9.2 Saudi Arabia
7.9.2.1 Saudi Arabia Veterinary API manufacturing Market, 2016 – 2028 (USD Million)
7.9.3 South Africa
7.9.3.1 South Africa Veterinary API manufacturing Market, 2016 – 2028 (USD Million)
Chapter 8 Veterinary API manufacturing Market: Competitive Analysis
8.1 Market Participation Categorization
8.2 Company Market Share/Position Analysis, 2020
8.2.1 List of Veterinary API Manufacturers
8.2.2 List of Emerging Companies in Veterinary API manufacturing
8.3 Recent Developments & Impact Analysis, By Key Market Participants
8.3.1 MAJOR DEALS & STRATEGIC ALLIANCE ANALYSIS
8.3.1.1 Product Approvals
8.3.1.2 Acquisitions
8.3.1.3 Expansion
8.3.2 MARKET ENTRY STRATEGIES
Chapter 9 Competitive Landscape
9.1 Company Profiles
9.1.1 Alivira Animal Health Limited
9.1.1.1 Company Overview
9.1.1.2 Financial Performance
9.1.1.3 Product Benchmarking
9.1.1.4 Strategic Initiatives
9.1.2 Excel Industries Ltd
9.1.2.1 Company Overview
9.1.2.2 Financial Performance
9.1.2.3 Product Benchmarking
9.1.2.4 Strategic Initiatives
9.1.3 Ofichem Group
9.1.3.1 Company Overview
9.1.3.2 Financial Performance
9.1.3.3 Product Benchmarking
9.1.3.4 Strategic Initiatives
9.1.4 Shaanxi Hanjiang Pharmaceutical Group Co.,Ltd.
9.1.4.1 Company Overview
9.1.4.2 Financial Performance
9.1.4.3 Product Benchmarking
9.1.4.4 Strategic Initiatives
9.1.5 Menadiona
9.1.5.1 Company Overview
9.1.5.2 Financial Performance
9.1.5.3 Product Benchmarking
9.1.5.4 Strategic Initiatives
9.1.6 Afton Pharma
9.1.6.1 Company Overview
9.1.6.2 Financial Performance
9.1.6.3 Product Benchmarking
9.1.6.4 Strategic Initiatives
9.1.7 Jiangsu Lingyun Pharmaceutical Co., Ltd.
9.1.7.1 Company Overview
9.1.7.2 Financial Performance
9.1.7.3 Product Benchmarking
9.1.7.4 Strategic Initiatives
9.1.8 SUANFARMA
9.1.8.1 Company Overview
9.1.8.2 Financial Performance
9.1.8.3 Product Benchmarking
9.1.8.4 Strategic Initiatives
9.1.9 NGL Fine-Chem Ltd.
9.1.9.1 Company Overview
9.1.9.2 Financial Performance
9.1.9.3 Product Benchmarking
9.1.9.4 Strategic Initiatives
9.1.10 FIS – Fabbrica Italiana Sintetici S.p.A
9.1.10.1 Company Overview
9.1.10.2 Financial Performance
9.1.10.3 Product Benchmarking
9.1.10.4 Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 Number of veterinarians in the U.S.
Table 3 List of Veterinary API manufacturers
Table 4 List of emerging/potential companies
Table 5 North America Veterinary API manufacturing market estimates and forecasts, by Service Type, 2016 - 2028 (USD Million)
Table 6 North America Veterinary API manufacturing market estimates and forecasts, by Synthesis Type, 2016 - 2028 (USD Million)
Table 7 North America Veterinary API manufacturing market estimates and forecasts, by Product, 2016 - 2028 (USD Million)
Table 8 The U.S. Veterinary API manufacturing market estimates and forecasts, by Service Type, 2016 - 2028 (USD Million)
Table 9 The U.S. Veterinary API manufacturing market estimates and forecasts, by Synthesis Type, 2016 - 2028 (USD Million)
Table 10 The U.S. Veterinary API manufacturing market estimates and forecasts, by Product, 2016 - 2028 (USD Million)
Table 11 Canada Veterinary API manufacturing market estimates and forecasts, by Service Type, 2016 - 2028 (USD Million)
Table 12 Canada Veterinary API manufacturing market estimates and forecasts, by Synthesis Type, 2016 - 2028 (USD Million)
Table 13 Canada Veterinary API manufacturing market estimates and forecasts, by Product, 2016 - 2028 (USD Million)
Table 14 Europe Veterinary API manufacturing market estimates and forecasts, by Service Type, 2016 - 2028 (USD Million)
Table 15 Europe Veterinary API manufacturing market estimates and forecasts, by Synthesis Type, 2016 - 2028 (USD Million)
Table 16 Europe Veterinary API manufacturing market estimates and forecasts, by Product, 2016 - 2028 (USD Million)
Table 17 The U.K. Veterinary API manufacturing market estimates and forecasts, by Service Type, 2016 - 2028 (USD Million)
Table 18 The U.K. Veterinary API manufacturing market estimates and forecasts, by Synthesis Type, 2016 - 2028 (USD Million)
Table 19 The U.K. Veterinary API manufacturing market estimates and forecasts, by Product, 2016 - 2028 (USD Million)
Table 20 Germany Veterinary API manufacturing market estimates and forecasts, by Service Type, 2016 - 2028 (USD Million)
Table 21 Germany Veterinary API manufacturing market estimates and forecasts, by Synthesis Type, 2016 - 2028 (USD Million)
Table 22 Germany Veterinary API manufacturing market estimates and forecasts, by Product, 2016 - 2028 (USD Million)
Table 23 France Veterinary API manufacturing market estimates and forecasts, by Service Type, 2016 - 2028 (USD Million)
Table 24 France Veterinary API manufacturing market estimates and forecasts, by Synthesis Type, 2016 - 2028 (USD Million)
Table 25 France Veterinary API manufacturing market estimates and forecasts, by Product, 2016 - 2028 (USD Million)
Table 26 Italy Veterinary API manufacturing market estimates and forecasts, by Service Type, 2016 - 2028 (USD Million)
Table 27 Italy Veterinary API manufacturing market estimates and forecasts, by Synthesis Type, 2016 - 2028 (USD Million)
Table 28 Italy Veterinary API manufacturing market estimates and forecasts, by Product, 2016 - 2028 (USD Million)
Table 29 Spain Veterinary API manufacturing market estimates and forecasts, by Service Type, 2016 - 2028 (USD Million)
Table 30 Spain Veterinary API manufacturing market estimates and forecasts, by Synthesis Type, 2016 - 2028 (USD Million)
Table 31 Spain Veterinary API manufacturing market estimates and forecasts, by Product, 2016 - 2028 (USD Million)
Table 32 Asia Pacific Veterinary API manufacturing market estimates and forecasts, by Service Type, 2016 - 2028 (USD Million)
Table 33 Asia Pacific Veterinary API manufacturing market estimates and forecasts, by Synthesis Type, 2016 - 2028 (USD Million)
Table 34 Asia Pacific Veterinary API manufacturing market estimates and forecasts, by Product, 2016 - 2028 (USD Million)
Table 35 Japan Veterinary API manufacturing market estimates and forecasts, by Service Type, 2016 - 2028 (USD Million)
Table 36 Japan Veterinary API manufacturing market estimates and forecasts, by Synthesis Type, 2016 - 2028 (USD Million)
Table 37 Japan Veterinary API manufacturing market estimates and forecasts, by Product, 2016 - 2028 (USD Million)
Table 38 China Veterinary API manufacturing market estimates and forecasts, by Service Type, 2016 - 2028 (USD Million)
Table 39 China Veterinary API manufacturing market estimates and forecasts, by Synthesis Type, 2016 - 2028 (USD Million)
Table 40 China Veterinary API manufacturing market estimates and forecasts, by Product, 2016 - 2028 (USD Million)
Table 41 India Veterinary API manufacturing market estimates and forecasts, by Service Type, 2016 - 2028 (USD Million)
Table 42 India Veterinary API manufacturing market estimates and forecasts, by Synthesis Type, 2016 - 2028 (USD Million)
Table 43 India Veterinary API manufacturing market estimates and forecasts, by Product, 2016 - 2028 (USD Million)
Table 44 Latin America Veterinary API manufacturing market estimates and forecasts, by Synthesis Type, 2016 - 2028 (USD Million)
Table 45 Latin America Veterinary API manufacturing market estimates and forecasts, by Product, 2016 - 2028 (USD Million)
Table 46 Brazil Veterinary API manufacturing market estimates and forecasts, by Service Type, 2016 - 2028 (USD Million)
Table 47 Brazil Veterinary API manufacturing market estimates and forecasts, by Synthesis Type, 2016 - 2028 (USD Million)
Table 48 Brazil Veterinary API manufacturing market estimates and forecasts, by Product, 2016 - 2028 (USD Million)
Table 49 Mexico Veterinary API manufacturing market estimates and forecasts, by Service Type, 2016 - 2028 (USD Million)
Table 50 Mexico Veterinary API manufacturing market estimates and forecasts, by Synthesis Type, 2016 - 2028 (USD Million)
Table 51 Mexico Veterinary API manufacturing market estimates and forecasts, by Product, 2016 - 2028 (USD Million)
Table 52 MEA Veterinary API manufacturing market estimates and forecasts, by Service Type, 2016 - 2028 (USD Million)
Table 53 MEA Veterinary API manufacturing market estimates and forecasts, by Synthesis Type, 2016 - 2028 (USD Million)
Table 54 MEA Veterinary API manufacturing market estimates and forecasts, by Product, 2016 - 2028 (USD Million)
Table 55 South Africa Veterinary API manufacturing market estimates and forecasts, by Service Type, 2016 - 2028 (USD Million)
Table 56 South Africa Veterinary API manufacturing market estimates and forecasts, by Synthesis Type, 2016 - 2028 (USD Million)
Table 57 South Africa Veterinary API manufacturing market estimates and forecasts, by Product, 2016 - 2028 (USD Million)
Table 58 Saudi Arabia Veterinary API manufacturing market estimates and forecasts, by Service Type, 2016 - 2028 (USD Million)
Table 59 Saudi Arabia Veterinary API manufacturing market estimates and forecasts, by Synthesis Type, 2016 - 2028 (USD Million)
Table 60 Saudi Arabia Veterinary API manufacturing market estimates and forecasts, by Product, 2016 - 2028 (USD Million)


List of Figures

Fig. 1 Veterinary API manufacturing market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Commodity Flow Analysis
Fig. 9 Veterinary API manufacturing market outlook 2020 (USD Million)
Fig. 10 Segment Outlook
Fig. 11 Parent market outlook
Fig. 12 Ancillary market outlook
Fig. 13 Penetration & growth prospect mapping by end use, 2020
Fig. 14 Veterinary API manufacturing market driver analysis
Fig. 15 Veterinary API manufacturing market driver analysis
Fig. 16 Estimated pet population in the U.S., 2015–2019, Million
Fig. 17 Total pet expenditure in the U.S., 2010–2019, Billion
Fig. 18 Veterinary API manufacturing market restraint impact
Fig. 19 Flow Diagram of API process
Fig. 20 Veterinary API manufacturing market: Service Type movement analysis
Fig. 21 Veterinary API manufacturing market service type outlook: Key takeaways
Fig. 22 In-house market, 2016 - 2028 (USD Million)
Fig. 23 Contract outsourcing market, 2016 - 2028 (USD Million)
Fig. 24 Contract development market, 2016 - 2028 (USD Million)
Fig. 25 Preclinical development market, 2016 - 2028 (USD Million)
Fig. 26 Others market, 2016 - 2028 (USD Million)
Fig. 27 Contract manufacturing market, 2016 - 2028 (USD Million)
Fig. 28 API/bulk drugs market, 2016 - 2028 (USD Million)
Fig. 29 Finished dose formulations market, 2016 - 2028 (USD Million)
Fig. 30 Veterinary API manufacturing market: Synthesis type movement analysis
Fig. 31 Veterinary API manufacturing market synthesis type outlook: Key takeaways
Fig. 32 Chemical-based API market, 2016 - 2028 (USD Million)
Fig. 33 Biological API market, 2016 - 2028 (USD Million)
Fig. 34 HPAPI market, 2016 - 2028 (USD Million)
Fig. 35 Veterinary API manufacturing market: Product movement analysis
Fig. 36 Veterinary API manufacturing market product outlook: Key takeaways
Fig. 37 Antiparasitic market, 2016 - 2028 (USD Million)
Fig. 38 Anti-infectives market, 2016 - 2028 (USD Million)
Fig. 39 NSAIDS market, 2016 - 2028 (USD Million)
Fig. 40 Vaccines market, 2016 - 2028 (USD Million)
Fig. 41 Biologics market, 2016 - 2028 (USD Million)
Fig. 42 Others market, 2016 - 2028 (USD Million)
Fig. 43 Regional outlook, 2020 & 2028
Fig. 44 Regional marketplace: Key takeaways
Fig. 45 North America veterinary API manufacturing market, by country, 2016 - 2028 (USD Million)
Fig. 46 The U.S. Veterinary API manufacturing market, 2016 - 2028 (USD Million)
Fig. 47 Canada veterinary API manufacturing market, 2016 - 2028 (USD Million)
Fig. 48 Europe veterinary API manufacturing market, by country, 2016 - 2028 (USD Million)
Fig. 49 The U.K. veterinary API manufacturing market, 2016 - 2028 (USD Million)
Fig. 50 Germany veterinary API manufacturing market, 2016 - 2028 (USD Million)
Fig. 51 France veterinary API manufacturing market, 2016 - 2028 (USD Million)
Fig. 52 Italy veterinary API manufacturing market, 2016 - 2028 (USD Million)
Fig. 53 Spain veterinary API manufacturing market, 2016 - 2028 (USD Million)
Fig. 54 Asia Pacific veterinary API manufacturing market, by country, 2016 - 2028 (USD Million)
Fig. 55 Japan veterinary API manufacturing market, 2016 - 2028 (USD Million)
Fig. 56 China veterinary API manufacturing market, 2016 - 2028 (USD Million)
Fig. 57 India veterinary API manufacturing market, 2016 - 2028 (USD Million)
Fig. 58 Latin America veterinary API manufacturing market, by country, 2016 - 2028 (USD Million)
Fig. 59 Brazil veterinary API manufacturing market, 2016 - 2028 (USD Million)
Fig. 60 Mexico veterinary API manufacturing market, 2016 - 2028 (USD Million)
Fig. 61 MEA veterinary API manufacturing market, by country, 2016 - 2028 (USD Million)
Fig. 62 Saudi Arabia veterinary API manufacturing market, 2016 - 2028 (USD Million)
Fig. 63 South Africa veterinary API manufacturing market, 2016 - 2028 (USD Million)
Fig. 64 Veterinary API manufacturing market: Participation categorization
Fig. 65 Companies market position analysis
Fig. 66 Strategy mapping

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の動物用医薬品有効成分製造市場2021-2028:サービスタイプ別(社内、契約アウトソーシング)、合成タイプ別、製品別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆